ARTG-Listed PRP System
To optimise patient safety & clinical versatility
A closed PRP workflow with high platelet recovery (90%), adjustable leukocyte inclusion, and five device sizes to support customisation of platelet dose, plasma volume and final injectate composition.
Designed for performance, safety, and clinical versatility, because regenerative medicine is not one-size-fits-all.
Supporting Australian & New Zealand clinicians and research facilities with latest technology & advanced use protocols.
Why Clinicians Choose Alocuro PRP & PRF for Their Patients?
PRP systems differ widely in their separation efficiency and consistency. Alocuro PRO‑PRP is engineered to deliver reproducible preparation with clinician‑guided control over platelet concentration, plasma volume, and leukocyte inclusion. Its performance has been extensively validated through independent testing in Australian pathology laboratories. During processing, the platelet layer becomes clearly visible and is directly transferred into the attached PRP collection syringe—without pipetting or aspiration—giving clinicians confidence in efficient, reliable platelet harvest every time.
The ARTG-listed & WAND-notified, closed-system devices deliver:
Average 90% platelet collection efficiency
Aseptic handling and sterility throughout every stage of PRP preparation
Clinician confidence that the expected platelet dose has been collected, due to visibility of platelets in EVERY procedure
Up to 9x baseline platelet concentration is possible. For comparison, most blood tube-type PRP systems typically produce 1.5 x baseline platelet concentration.
Clinical versatility, allowing adjustment of final PRP injectate volume and platelet concentration to match the treatment scope
Unique ability to customise leukocyte inclusion. For example, reduced leukocyte content may be preferred for intra-articular applications to treat OA symptoms , while selected tendon pathology (e.g. acute partial tendon tear) may utilise leukocyte-containing preparations.
Ultra-low neutrophil yield (<0.3%) for reduced post-procedure pain-flare.
Clinical Applications
Alocuro technology is used across a broad range of disciplines by healthcare professionals, including doctors, dentists, and registered nurses operating within appropriate clinical governance and supervision arrangements.
Platelets in PRP & PRF
PRP is not a single product, but a biologically active preparation whose composition varies based on platelet recovery, cellular profile, and final injectate volume. These variables influence the signalling environment delivered to the target tissue and are shaped by both patient baseline factors and preparation technique.
For this reason, reproducible separation, controlled platelet capture, and the ability to adjust leukocyte inclusion are central to protocol-led PRP practice. Systems that offer limited recovery or fixed outputs may introduce unnecessary variability between patients and indications.
Alocuro’s platelet-concentrating system is designed to support this biological complexity, giving clinicians practical control over preparation parameters so PRP can be aligned with tissue environment, indication, and clinical intent.
Why System Design Matters
Alocuro system provide clinicians with a science-led, customisable and clinically governed platform, delivering confidence, consistency and performance in patient’s own regenerative medicine.
Alocuro System Offers
High-Efficiency Platelet Recovery: Patented processing technology maximises platelet capture while allowing precise control over plasma volume, supporting concentrated PRP and PRF preparations without unnecessary dilution.
Consistency: Alocuro systems are designed to deliver clinically meaningful platelet concentrations, helping practitioners achieve dependable biological activity across patients and indications.
Precision & Control: Clinicians can control key variables including platelet density, plasma volume and preparation type, enabling treatments to be tailored to individual patient needs and treatment goals.
Safety-Focused Design: Alocuro PRP processing and transfer of PRP or PRF occurs within a single-use, sterile, closed, ARTG-listed system, aligned with validated clinical protocols to reduce contamination risk and support patient safety.
